Loading…
Quick answer: Acesulfame Potassium carries the heavier risk profile. Acesulfame Potassium is — in the EU and — in the US; Retinyl palmitate is restricted in the EU and allowed in the US.
| Property | Acesulfame Potassium | Retinyl palmitate |
|---|---|---|
| EU status | — | Restricted |
| US status | — | Allowed |
| Risk level | — | medium |
| Banned in | — | — |
| Restricted in | European Union (ADI 9 mg/kg body weight; must be labeled E950 or 'sweetener'), Australia, Canada | European Union |
| Category | additive | endocrine disruptor |
| Where it hides | — | anti-aging cream, sunscreen, lotion |
Acesulfame potassium (Ace-K) is a calorie-free synthetic sweetener approximately 200 times sweeter than sucrose. It contains a potassium atom bonded to an oxathiazinone dioxide ring structure. It is heat-stable and non-metabolized, passing through the body unchanged. Often blended with sucralose or aspartame to mask bitter aftertaste.
Retinyl palmitate is a vitamin A ester used in anti-aging skincare and sunscreen.
Acesulfame Potassium: The safety database for Ace-K is considered less comprehensive than that for other sweeteners. Critics have argued that the original FDA approval studies from the 1970s-1980s were insufficient in quality and length to definitively establish long-term safety. The Center for Science in the Public Interest (CSPI) has petitioned for additional testing. Two rat studies found statistically significant increases in lung tumors (in male rats) and mammary tumors at high doses. Regulatory agencies have argued these doses far exceeded typical human exposure and attributed the tumor findings to other factors. However, the question of whether Ace-K's approval studies meet modern standards has been raised by independent researchers. A 2021 study in Cell found that Ace-K and other non-nutritive sweeteners altered gut microbiome composition and affected glucose tolerance in some human participants. Ace-K specifically was associated with changes in gut bacteria that correlated with glycemic effects. Neurological concerns: some animal studies suggest Ace-K may affect brain neurotransmitter systems. A 2013 study in PLoS ONE found that Ace-K consumption in pregnant mice altered offspring postnatal taste preference and increased weight gain, suggesting potential transgenerational effects. These findings were at doses exceeding typical human intake. Endocrine disruption potential has been raised in some in vitro studies, but comprehensive human data are lacking.
Retinyl palmitate: The EU caps vitamin A levels over concerns it may accelerate skin damage in sunlight; the US does not restrict it.
Scan a barcode and we'll flag both Acesulfame Potassium and Retinyl palmitate (plus 200+ other ingredients banned overseas).
Scan free →